Clinical Value of Sequential Gefitinib With Pemetrexed/Platinum for Advanced NSCLC

Efficacy and Safety of Use of Platinum Based Doublet Chemotherapy Plus Antiangiogenesis and Immune Checkpoint Inhibitors in Patients With Advanced Non-squamous Non-small Cell Lung Cancer

NCT04137588 ·Status: UNKNOWN

Pemetrexed Plus Cisplatin Versus Gemcitabine Plus Cisplatin for Advanced NSCLC Metastatic Non-small Cell Lung Cancer

NCT01194453 ·Status: COMPLETED ·Phase: PHASE2

Chemotherapy Combination With Local Radiotherapy and rhGM-CSF for Oligometastatic Stage IV NSCLC Patients

NCT03489616 ·Status: UNKNOWN ·Phase: NA

Study of Concurrent Pemetrexed, Cisplatin and Radiotherapy in Local Advanced Non-Small Cell Lung Cancer

NCT00846443 ·Status: UNKNOWN ·Phase: PHASE1

Safety and Efficacy Study of Pemetrexed + Platinum Chemotherapy + Pembrolizumab (MK-3475) With or Without Lenvatinib (MK-7902/E7080) as First-line Intervention in Adults With Metastatic Nonsquamous Non-small Cell Lung Cancer (MK-7902-006/E7080-G000-315/LEAP-006)-China Extension Study

NCT04716933 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Biomarker Development for Lung Cancer Treated With Immune Checkpoint Inhibitors

NCT05055908 ·Status: RECRUITING ·Phase: PHASE3

Maintenance Gemcitabine in the Chinese Advanced Lung Cancer

NCT01336192 ·Status: UNKNOWN ·Phase: PHASE4

Induction Therapy With PD-1 Antibody Combined With Platinum-based Doublet Chemotherapy for Locally-advanced Non-small Cell Lung Cancer

NCT05766800 ·Status: RECRUITING ·Phase: PHASE2

A Phase II Study of SSGJ-707 Combination Therapy in Advanced NSCLC Patients

NCT06412471 ·Status: RECRUITING ·Phase: PHASE2

Effect of Chemotherapy on TMB in NSCLC

NCT03683407 ·Status: UNKNOWN

SMET12 and Toripalimab Combined Chemotherapy in Patients With EGFR Positive Advanced Non-small Cell Lung Cancer (NSCLC)

NCT06208033 ·Status: NOT_YET_RECRUITING ·Phase: EARLY_PHASE1

A Clinical Study of SPH6516 Tablets in the Treatment of Advanced Solid Tumors.

NCT06266923 ·Status: COMPLETED ·Phase: EARLY_PHASE1

Efficacy and Safety of Conventional and Low-dose Platinum Gemcitabine Combined With Cindilimab With Delayed Administration in First-line Treatment of Advanced Squamous Non-small Cell Lung Cancer

NCT05312840 ·Status: UNKNOWN ·Phase: PHASE4

A Randomized Study of Primary Tumor Radiotherapy for Patients With MPE Stage IV NSCLC

NCT03987087 ·Status: UNKNOWN ·Phase: PHASE2

Vebreltinib for Neoadjuvant in METex 14 Skipping Mutant Stage IIA-IIIB (N2) Non-small Cell Lung Cancer (NSCLC)

NCT07156604 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

A Study of PM1022 in Patients With Advanced Tumors

NCT05867771 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2

First-line Treatment for ES-SCLC with Chemotherapy Combined with PD-1/PD-L1 Inhibitor Sequential Thoracic Radiotherapy

NCT06586697 ·Status: RECRUITING ·Phase: PHASE2

Standard-of-care Systemic Therapy With or Without Local Therapy in Patients With Oligoprogressive Non-Small Cell Lung Cancer(NSCLC）

NCT07076693 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2/PHASE3

A Study Comparing BL-B01D1 With Platinum Based Chemotherapy in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer(PANKU-Lung01)

NCT06382116 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Low-dose Gemcitabine Combined With Nivolumab for Second-line and Above Line Treatment of NSCLC

NCT04331626 ·Status: UNKNOWN ·Phase: PHASE4

Real-world First-line Sugemalimab-Chemotherapy in Advanced NSCLC

NCT07247227 ·Status: RECRUITING ·Phase: NA

Study of KN046 With Chemotherapy in First Line Advanced NSCLC

NCT04054531 ·Status: UNKNOWN ·Phase: PHASE2

The Optimal Intervention Time of Radiotherapy for Oligometastatic Stage IV Non-small Cell Lung Cancer（NSCLC）

NCT02076477 ·Status: UNKNOWN ·Phase: PHASE3

Pemetrexed as Salvage Treatment in Squamous Cell Carcinoma of Head and Neck

NCT01333696 ·Status: UNKNOWN ·Phase: PHASE2

Icotinib With Concurrent Radiotherapy vs. Chemoradiotherapy in Non-small Cell Lung Cancer

NCT02407366 ·Status: UNKNOWN ·Phase: PHASE2